Sweden· SE-20120105000027
ADASUVE 9,1 mg Inhalationspulver, avdelad dos
A medicinal product containing loxapine, registered in Sweden by Ferrer Internacional, SA..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Loxapine
- Manufacturer
- Ferrer Internacional, SA.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20120105000027
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Loxapine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaADASUVEFerrer Internacional, S.A., Barcelona
- SpainADASUVE 9,1 MG POLVO PARA INHALACION (UNIDOSIS)Ferrer Internacional S.A.
- United KingdomAdasuve 9.1mg/dose inhalation powderGalen Ltd
- IrelandADASUVE 9.1 mg inhalation powder, pre-dispensedFerrer Internacional, S.A
- IcelandAdasuveFerrer Internacional S.A.
- NetherlandsAdasuve 9,1 mg inhalatiepoeder, voorverdeeldFerrer Internacional S.A.
- BelgiumAdasuve 9.1 mgAlexza UK
- PolandAdasuveFerrer Internacional, S.A.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- France · Loxapac, Loxapine Arrow
- Iceland · Adasuve
- Liechtenstein · Adasuve
- Norway · Adasuve
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/15b313c5-1608-46cf-8c88-d68db782f97a GET /v1/drugs/15b313c5-1608-46cf-8c88-d68db782f97a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20120105000027",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20120105000027",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/adasuve"
}See everything about loxapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.